Wockhardt, one of India's largest drug makers, is seeking shareholders' nod to raise up to Rs 1,000 crore via issue of securities. The company is seeking the approval via a postal ballot for raising additional capital by way of one or more public or private offerings including through a qualified institutions placement (QIP). The shareholders can approve the resolution through e-voting or physical postal ballot form. The voting period for the company's shareholders begins on May 10 and ends on June 8, 2017.
Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1672.70 |
| Dr. Reddys Lab | 1239.00 |
| Cipla | 1239.40 |
| Zydus Lifesciences | 942.95 |
| Lupin | 2336.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: